Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
testosterone + somatropin
- Development stage
- Preclinical
- Lead developer
- Mattern Pharma
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Transdermal, Subcutaneous
01
Overview
A combination therapy consisting of testosterone and somatropin (recombinant human growth hormone). This combination has been studied for its synergistic effects on increasing lean body mass, muscle strength, and aerobic endurance while reducing body fat. The two hormones appear to work together to enhance anabolic processes in the body more effectively than either hormone alone.
- Brand names
- AndroGel
- Other names
- Testosterone plus somatropinTestosterone and Growth HormoneDual hormone replacement therapy
02
Targets
GHR (Growth hormone receptor)AR (Adrenergic receptors)
Beyond the preview
Go deeper on testosterone + somatropin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on testosterone + somatropin.